Apama Medical, Inc., a Campbell, CA-based medical device company focused on the development of next-generation atrial fibrillation technologies, raised $11.0M in the first tranche of its $17.5M Series B financing.
Apama Medical is a portfolio company incubated out of Shifamed, LLC, and supported with an existing National Science Foundation grant.
The round was led by Ascension Ventures, with participation from Medvance Incubator Partners, ONSET Ventures and Incept, LLC and angel investors. In conjunction with the deal, representatives from the above mentioned firms, will join Apama’s Board of Directors.
Led by CEO Amr Salahieh, also Founder and Chairman of Shifamed, and Gregory D. Casciaro, Executive Chairman, Apama Medical is a privately held medical device company focused on the electrophysiology market which offers a catheter-based solution for atrial fibrillation (AF) ablation, which is expected to reach $1.7 billion in 2017.